Nursing5336 FNP Exam 2 2025/26 With I!% I!% I!% I !% I!%
complete solution Guaranteed Success
I!% I!% I!% I!%
2017 ACC/AHA guidelines: normal BP - <120 / <80
I!%
I!% I!% I!% I!% I!% I!% I!% I!% I!%
2017 ACC/AHA guidelines: elevated BP - 120-129/ <80
I!%
I!% I!% I!% I!% I!% I!% I!% I!%
2017 ACC/AHA guidelines: stage 1 HTN - 130--89
I!%
I!% I!% I!% I!% I!% I!% I!% I!% I!% I!%
2017 ACC/AHA guidelines: stage 2 HTN - ≥ 140/ ≥ 90
I!%
I!% I!% I!% I!% I!% I!% I!% I!% I!% I!% I!%
What is recommended for white coat hypertension? - - lifestyle modification
I!% I!% I!% I!%
I!%
I!% I!% I!% I!% I!% I!%
- annual ABPM or HBPM
I!%
I!% I!% I!% I!%
What is recommended for masked hypertension? - - lifestyle modification
I!% I!% I!%
I!%
I!% I!% I!% I!% I!% I!%
- start HTN medication
I!%
I!% I!% I!%
What is recommended for elevated BP? - - lifestyle modification
I!% I!%
I!%
I!% I!% I!% I!% I!% I!% I!%
- annual ABPM
I!%
I!% I!%
What is secondary hypertension? - - drug resistant/induced hypertension
I!% I!% I!% I!% I!% I!% I!%
I!%
I!%
- exacerbation of previously controlled hypertension
I!% I!% I!% I!% I!%
I!%
- accelerated/malignant hypertension
I!% I!%
I!%
- unprovoked or excessive hypokalemia
I!%
I!% I!% I!% I!%
What are common causes of secondary hypertension? - - renal disease
I!% I!%
I!%
I!% I!% I!% I!% I!% I!% I!% I!%
- aldosteronism
I!%
I!%
- OSA I!%
I!%
- drug and alcohol induced
I!%
I!% I!% I!% I!%
What are non-pharmacological interventions for hypertension? - - weight loss -
I!% I!% I!% I!% I!% I!% I!% I!% I!% I!%
DASH diet
I!% I!% I!%
- sodium reduction I!% I!%
- potassium supplementation I!% I!%
- reduce alcohol consumption
I!%
I!% I!% I!%
2017 ACC/AHA guidelines: clinical CVD and BP ≥ 130 / ≥ 80 - use BP lowering
I!%
I!%
I!% I!% I!% I!% I!% I!% I!% I!% I!% I!% I!% I!% I!% I!% I!%
meds
I!%
2017 ACC/AHA guidelines: primary prevention in adults 10 yr ASCVD risk of ≥ 10% -
I!% I!%
I!%
I!% I!% I!% I!% I!% I!% I!% I!% I!% I!% I!% I!%
use BP lowering meds
I!%
I!% I!% I!%
2017 ACC/AHA guidelines: 10 yr risk < 10% and SBP ≥ 140/90 - use BP lowering
I!%
I!%
I!% I!% I!% I!% I!% I!% I!% I!% I!% I!% I!% I!% I!% I!% I!%
meds
I!%
2017 ACC/AHA guidelines: normal BP reassessment - yearly
I!%
I!% I!% I!% I!% I!% I!% I!% I!%
2017 ACC/AHA guidelines: elevated BP reassessment - 3-6 months
I!%
I!% I!% I!% I!% I!% I!% I!% I!% I!%
2017 ACC/AHA guidelines: stage 1 HTN reassessment and 10 yr ASCVD < 10% - 3-
I!%
I!%
I!% I!% I!% I!% I!% I!% I!% I!% I!% I!% I!% I!% I!%
6 months
I!%
I!%
2017 ACC/AHA guidelines: stage 2 HTN reassessment - one month until goal BP
I!% I!%
I!%
I!% I!% I!% I!% I!% I!% I!% I!% I!% I!% I!%
met, then 3-6 months
I!%
I!% I!% I!%
2017 ACC/AHA guidelines: stage 1 HTN reassessment and 10 yr ASCVD > 10% -
I!% I!% I!% I!% I!% I!%
I!%
I!% I!% I!% I!% I!% I!% I!%
one month until BP goal met, then 3-6 months
I!%
I!% I!% I!% I!% I!% I!% I!% I!%
What hypertensive medications should not be prescribed simultaneously? - - ACE
I!%
I!%
I!% I!% I!% I!% I!% I!% I!% I!% I!%
- ARB I!%
, I!%
- Renin Inhibitor
I!%
I!% I!%
2017 ACC/AHA guidelines: first line agents - - thiazide diuretics
I!% I!% I!% I!% I!% I!% I!% I!% I!% I!%
- CCBs I!%
- ACE I!%
- ARBs
I!%
I!%
2017 ACC/AHA guidelines: initiation of drug therapy in stage 2 HTN - initiate drug
I!% I!% I!% I!% I!% I!% I!% I!% I!% I!% I!% I!% I!%
therapy with 2 first line medications of different classes as separate agents or combo
I!% I!% I!% I!% I!% I!% I!% I!% I!% I!% I!% I!% I!% I!%
drug
I!%
I!%
I!%
2017 ACC/AHA guidelines: initiation of drug therapy in stage 1 HTN - initiate therapy
I!% I!%
I!%
I!% I!% I!% I!% I!% I!% I!% I!% I!% I!% I!% I!%
with a single drug
I!%
I!% I!% I!%
2017 ACC/AHA guidelines: HTN reassessment for new or adjusted drug regimen -
I!% I!% I!% I!% I!% I!% I!%
I!%
I!% I!% I!% I!%
follow up at monthly intervals until control is sustained
I!%
I!% I!% I!% I!% I!% I!% I!% I!%
2017 ACC/AHA guidelines: black adults with HTN, no HF or CKD - initiate therapy
I!% I!% I!%
I!%
I!% I!% I!% I!% I!% I!% I!% I!% I!% I!% I!%
with thiazide diuretic or CCB
I!%
I!% I!% I!% I!%
2017 ACC/AHA guidelines: pregnant or planning pregnancy safe drug choice - -
I!% I!% I!% I!% I!% I!% I!% I!% I!% I!% I!%
methyldopa
I!% I!%
- nifedipine I!%
- labetalol
I!%
I!%
2017 ACC/AHA guidelines: drugs contraindicated in pregnant women - - ACE
I!%
I!%
I!% I!% I!% I!% I!% I!% I!% I!% I!%
- ARBsI!%
I!%
- direct renin inhibitors
I!%
I!% I!% I!%
2017 ACC/AHA vs JNC 8 older community dwelling adults ≥ 65 yo - - JNC 8 treat BP
I!%
I!%
I!% I!% I!% I!% I!% I!% I!% I!% I!% I!% I!% I!% I!% I!% I!% I!% I!%
if > 150/90 I!% I!%
I!%
- 2017 treat if SBP ≥ 130
I!%
I!% I!% I!% I!% I!% I!%
2017 ACC/AHA guidelines: hypertensive crisis - > 180/120
I!% I!% I!%
I!%
I!% I!% I!% I!%
admit to ICU if target organ damage
I!%
I!% I!% I!% I!% I!% I!%
2017 ACC/AHA guidelines: secondary stroke prevention BP threshold - ≥ 140/90
I!%
I!% I!% I!% I!% I!% I!% I!% I!% I!% I!% I!%
2017 ACC/AHA guidelines: no CVD and ASCVD risk < 10% BP threshold - ≥ 140/90
I!%
I!% I!% I!% I!% I!% I!% I!% I!% I!% I!% I!% I!% I!% I!% I!%
TOD brain - - CVA I!% I!% I!% I!% I!%
I!%
- encephalopathy
I!%
I!%
- dementia
I!%
I!%
- multi infarct
I!% I!%
- early cognitive decline
I!%
I!% I!% I!%
TOD eyes - - flame hemorrhage I!% I!% I!% I!% I!% I!%
- papilloedema I!%
- hard exudates I!% I!%
- cotton wool spots
I!%
I!% I!% I!%
TOD heart - - LVH I!% I!% I!% I!% I!%
- CAD I!%
- MI I!%
- rhythm disorders I!% I!%
- aortic and PAD I!% I!% I!%
- AAA
I!%
I!%
TOD kidneys - - CKD I!% I!% I!% I!%
complete solution Guaranteed Success
I!% I!% I!% I!%
2017 ACC/AHA guidelines: normal BP - <120 / <80
I!%
I!% I!% I!% I!% I!% I!% I!% I!% I!%
2017 ACC/AHA guidelines: elevated BP - 120-129/ <80
I!%
I!% I!% I!% I!% I!% I!% I!% I!%
2017 ACC/AHA guidelines: stage 1 HTN - 130--89
I!%
I!% I!% I!% I!% I!% I!% I!% I!% I!% I!%
2017 ACC/AHA guidelines: stage 2 HTN - ≥ 140/ ≥ 90
I!%
I!% I!% I!% I!% I!% I!% I!% I!% I!% I!% I!%
What is recommended for white coat hypertension? - - lifestyle modification
I!% I!% I!% I!%
I!%
I!% I!% I!% I!% I!% I!%
- annual ABPM or HBPM
I!%
I!% I!% I!% I!%
What is recommended for masked hypertension? - - lifestyle modification
I!% I!% I!%
I!%
I!% I!% I!% I!% I!% I!%
- start HTN medication
I!%
I!% I!% I!%
What is recommended for elevated BP? - - lifestyle modification
I!% I!%
I!%
I!% I!% I!% I!% I!% I!% I!%
- annual ABPM
I!%
I!% I!%
What is secondary hypertension? - - drug resistant/induced hypertension
I!% I!% I!% I!% I!% I!% I!%
I!%
I!%
- exacerbation of previously controlled hypertension
I!% I!% I!% I!% I!%
I!%
- accelerated/malignant hypertension
I!% I!%
I!%
- unprovoked or excessive hypokalemia
I!%
I!% I!% I!% I!%
What are common causes of secondary hypertension? - - renal disease
I!% I!%
I!%
I!% I!% I!% I!% I!% I!% I!% I!%
- aldosteronism
I!%
I!%
- OSA I!%
I!%
- drug and alcohol induced
I!%
I!% I!% I!% I!%
What are non-pharmacological interventions for hypertension? - - weight loss -
I!% I!% I!% I!% I!% I!% I!% I!% I!% I!%
DASH diet
I!% I!% I!%
- sodium reduction I!% I!%
- potassium supplementation I!% I!%
- reduce alcohol consumption
I!%
I!% I!% I!%
2017 ACC/AHA guidelines: clinical CVD and BP ≥ 130 / ≥ 80 - use BP lowering
I!%
I!%
I!% I!% I!% I!% I!% I!% I!% I!% I!% I!% I!% I!% I!% I!% I!%
meds
I!%
2017 ACC/AHA guidelines: primary prevention in adults 10 yr ASCVD risk of ≥ 10% -
I!% I!%
I!%
I!% I!% I!% I!% I!% I!% I!% I!% I!% I!% I!% I!%
use BP lowering meds
I!%
I!% I!% I!%
2017 ACC/AHA guidelines: 10 yr risk < 10% and SBP ≥ 140/90 - use BP lowering
I!%
I!%
I!% I!% I!% I!% I!% I!% I!% I!% I!% I!% I!% I!% I!% I!% I!%
meds
I!%
2017 ACC/AHA guidelines: normal BP reassessment - yearly
I!%
I!% I!% I!% I!% I!% I!% I!% I!%
2017 ACC/AHA guidelines: elevated BP reassessment - 3-6 months
I!%
I!% I!% I!% I!% I!% I!% I!% I!% I!%
2017 ACC/AHA guidelines: stage 1 HTN reassessment and 10 yr ASCVD < 10% - 3-
I!%
I!%
I!% I!% I!% I!% I!% I!% I!% I!% I!% I!% I!% I!% I!%
6 months
I!%
I!%
2017 ACC/AHA guidelines: stage 2 HTN reassessment - one month until goal BP
I!% I!%
I!%
I!% I!% I!% I!% I!% I!% I!% I!% I!% I!% I!%
met, then 3-6 months
I!%
I!% I!% I!%
2017 ACC/AHA guidelines: stage 1 HTN reassessment and 10 yr ASCVD > 10% -
I!% I!% I!% I!% I!% I!%
I!%
I!% I!% I!% I!% I!% I!% I!%
one month until BP goal met, then 3-6 months
I!%
I!% I!% I!% I!% I!% I!% I!% I!%
What hypertensive medications should not be prescribed simultaneously? - - ACE
I!%
I!%
I!% I!% I!% I!% I!% I!% I!% I!% I!%
- ARB I!%
, I!%
- Renin Inhibitor
I!%
I!% I!%
2017 ACC/AHA guidelines: first line agents - - thiazide diuretics
I!% I!% I!% I!% I!% I!% I!% I!% I!% I!%
- CCBs I!%
- ACE I!%
- ARBs
I!%
I!%
2017 ACC/AHA guidelines: initiation of drug therapy in stage 2 HTN - initiate drug
I!% I!% I!% I!% I!% I!% I!% I!% I!% I!% I!% I!% I!%
therapy with 2 first line medications of different classes as separate agents or combo
I!% I!% I!% I!% I!% I!% I!% I!% I!% I!% I!% I!% I!% I!%
drug
I!%
I!%
I!%
2017 ACC/AHA guidelines: initiation of drug therapy in stage 1 HTN - initiate therapy
I!% I!%
I!%
I!% I!% I!% I!% I!% I!% I!% I!% I!% I!% I!% I!%
with a single drug
I!%
I!% I!% I!%
2017 ACC/AHA guidelines: HTN reassessment for new or adjusted drug regimen -
I!% I!% I!% I!% I!% I!% I!%
I!%
I!% I!% I!% I!%
follow up at monthly intervals until control is sustained
I!%
I!% I!% I!% I!% I!% I!% I!% I!%
2017 ACC/AHA guidelines: black adults with HTN, no HF or CKD - initiate therapy
I!% I!% I!%
I!%
I!% I!% I!% I!% I!% I!% I!% I!% I!% I!% I!%
with thiazide diuretic or CCB
I!%
I!% I!% I!% I!%
2017 ACC/AHA guidelines: pregnant or planning pregnancy safe drug choice - -
I!% I!% I!% I!% I!% I!% I!% I!% I!% I!% I!%
methyldopa
I!% I!%
- nifedipine I!%
- labetalol
I!%
I!%
2017 ACC/AHA guidelines: drugs contraindicated in pregnant women - - ACE
I!%
I!%
I!% I!% I!% I!% I!% I!% I!% I!% I!%
- ARBsI!%
I!%
- direct renin inhibitors
I!%
I!% I!% I!%
2017 ACC/AHA vs JNC 8 older community dwelling adults ≥ 65 yo - - JNC 8 treat BP
I!%
I!%
I!% I!% I!% I!% I!% I!% I!% I!% I!% I!% I!% I!% I!% I!% I!% I!% I!%
if > 150/90 I!% I!%
I!%
- 2017 treat if SBP ≥ 130
I!%
I!% I!% I!% I!% I!% I!%
2017 ACC/AHA guidelines: hypertensive crisis - > 180/120
I!% I!% I!%
I!%
I!% I!% I!% I!%
admit to ICU if target organ damage
I!%
I!% I!% I!% I!% I!% I!%
2017 ACC/AHA guidelines: secondary stroke prevention BP threshold - ≥ 140/90
I!%
I!% I!% I!% I!% I!% I!% I!% I!% I!% I!% I!%
2017 ACC/AHA guidelines: no CVD and ASCVD risk < 10% BP threshold - ≥ 140/90
I!%
I!% I!% I!% I!% I!% I!% I!% I!% I!% I!% I!% I!% I!% I!% I!%
TOD brain - - CVA I!% I!% I!% I!% I!%
I!%
- encephalopathy
I!%
I!%
- dementia
I!%
I!%
- multi infarct
I!% I!%
- early cognitive decline
I!%
I!% I!% I!%
TOD eyes - - flame hemorrhage I!% I!% I!% I!% I!% I!%
- papilloedema I!%
- hard exudates I!% I!%
- cotton wool spots
I!%
I!% I!% I!%
TOD heart - - LVH I!% I!% I!% I!% I!%
- CAD I!%
- MI I!%
- rhythm disorders I!% I!%
- aortic and PAD I!% I!% I!%
- AAA
I!%
I!%
TOD kidneys - - CKD I!% I!% I!% I!%
